Context Capital Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22K | Hold |
81,500
| – | – | ﹤0.01% | 420 |
|
|
2026
Q1 | $1.34K | Hold |
81,500
| – | – | ﹤0.01% | 386 |
|
|
2025
Q4 | $2.11K | Hold |
81,500
| – | – | ﹤0.01% | 319 |
|
|
2025
Q3 | $1.66K | Hold |
81,500
| – | – | ﹤0.01% | 264 |
|
|
2025
Q2 | $1.32K | Hold |
81,500
| – | – | ﹤0.01% | 246 |
|
|
2025
Q1 | $3.26K | Hold |
81,500
| – | – | ﹤0.01% | 194 |
|
|
2024
Q4 | $6.76K | Hold |
81,500
| – | – | ﹤0.01% | 192 |
|
|
2024
Q3 | $3.17K | Hold |
81,500
| – | – | ﹤0.01% | 256 |
|
|
2024
Q2 | $3.17K | Hold |
81,500
| – | – | ﹤0.01% | 207 |
|
|
2024
Q1 | $8.67K | Hold |
81,500
| – | – | ﹤0.01% | 201 |
|
|
2023
Q4 | $14.2K | Hold |
81,500
| – | – | ﹤0.01% | 169 |
|
|
2023
Q3 | $3K | Hold |
81,500
| – | – | ﹤0.01% | 263 |
|
|
2023
Q2 | $15K | Hold |
81,500
| – | – | ﹤0.01% | 183 |
|
|
2023
Q1 | $26K | Sell |
81,500
-40,000
| -33% | -$9.39K | ﹤0.01% | 203 |
|
|
2022
Q4 | $6K | Hold |
121,500
| – | – | ﹤0.01% | 349 |
|
|
2022
Q3 | $23K | Hold |
121,500
| – | – | ﹤0.01% | 411 |
|
|
2022
Q2 | $19K | Sell |
121,500
-3,500
| -3% | -$681 | ﹤0.01% | 471 |
|
|
2022
Q1 | $25K | Buy |
+125,000
| New | +$29.7K | ﹤0.01% | 559 |
|
Context Capital Management's CDIOW Position: Q2 2026 in Review
Context Capital Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q2 2026 at 81,500 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #420.
Context Capital Management first reported a position in CDIOW in Q1 2022 and has held it in 18 quarters since. The position peaked at $26K in Q1 2023. 1 fund tracked by Wall St. Rank holds CDIOW as of Q2 2026.
- Context Capital Management held 81,500 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.22K as of Q2 2026.
- Context Capital Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q2 2026.
- Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of Context Capital Management's portfolio in Q2 2026, its #420 holding.
- Context Capital Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 18 quarters since.
- Context Capital Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $26K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2026.
Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.